Cargando…
CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction
The heart faces the challenge of adjusting the rate of fatty acid uptake to match myocardial demand for energy provision at any given moment, avoiding both too low uptake rates, which could elicit an energy deficit, and too high uptake rates, which pose the risk of excess lipid accumulation and lipo...
Autores principales: | Glatz, Jan F.C., Luiken, Joost J.F.P., Nabben, Miranda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379071/ https://www.ncbi.nlm.nih.gov/pubmed/32821722 http://dx.doi.org/10.12997/jla.2020.9.1.66 |
Ejemplares similares
-
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
por: Glatz, Jan F.C., et al.
Publicado: (2022) -
Augmenting Vacuolar H(+)-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
por: Wang, Shujin, et al.
Publicado: (2020) -
Specific amino acid supplementation rescues the heart from lipid overload-induced insulin resistance and contractile dysfunction by targeting the endosomal mTOR–v-ATPase axis
por: Wang, Shujin, et al.
Publicado: (2021) -
Re-balancing cellular energy substrate metabolism to mend the failing heart(☆)
por: Glatz, Jan F.C., et al.
Publicado: (2019) -
Putative Role of Protein Palmitoylation in Cardiac Lipid-Induced Insulin Resistance
por: Schianchi, Francesco, et al.
Publicado: (2020)